NCT04229056

Brief Summary

This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to generally cognitively stimulating activities on a computer

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
307

participants targeted

Target at P75+ for not_applicable parkinson-disease

Timeline
2mo left

Started Jun 2020

Longer than P75 for not_applicable parkinson-disease

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Jun 2020Jun 2026

First Submitted

Initial submission to the registry

January 3, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 14, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

June 1, 2020

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

February 20, 2025

Status Verified

February 1, 2025

Enrollment Period

5.6 years

First QC Date

January 3, 2020

Last Update Submit

February 19, 2025

Conditions

Keywords

parkinson diseasestrokecardiac arrestexecutive dysfunctioncognitive dysfunctioncomputer-based cognitive rehabilitation

Outcome Measures

Primary Outcomes (1)

  • CABPad Working Memory Test

    Test of working memory. The higher score the better (theoretically infinite score)

    After the end of the intervention (8 weeks after baseline)

Secondary Outcomes (27)

  • CABPad Working Memory Test - 3 months follow-up

    At follow-up visit 3 months after end of intervention

  • Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)

    At follow-up visit 3 months after the end of the intervention

  • Trail Making A

    Directly after the intervention, eight weeks after inclusion

  • Trail Making A

    At follow-up visit 3 months after the end of the intervention

  • Trail Making B

    Directly after the intervention, eight weeks after inclusion

  • +22 more secondary outcomes

Study Arms (2)

Specific computer-based cognitive rehabilitation

EXPERIMENTAL

154 patients will be allocated to specific computer-based cognitive rehabilitation. This group will train with 10 exercises from the cognitive rehabilitation software 'Scientific Brain training PRO'. These 10 exercises are designed to train various executive functions.

Behavioral: Computer-based cognitive rehabilitation (CBCR)

General computer-based cognitive stimulation

ACTIVE COMPARATOR

154 patients will be allocated to general computer-based cognitive stimulation. This group will train with 10 generally mentally stimulating games on a website specifically designed for this trial. These 10 games are chosen because they are believed to have a low load on executive functions but stimulate over-all concentration and visuoperceptual abilities.

Behavioral: General computer-based cognitive stimulation

Interventions

CBCR are software-programmes for computers which are clinically developed for rehabilitation of various cognitive functions.

Specific computer-based cognitive rehabilitation

For this trial we have developed a webpage for general cognitive stimulation, which is designed to provide general computer-based cognitive stimulation.

General computer-based cognitive stimulation

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A diagnose of stroke, cardiac arrest or Parkinson's disease.
  • Aged 18 years or older.
  • Computer and internet access at home.
  • Providing informed consent.
  • Stroke confirmed by clinical findings and imaging, both AIS and ICH is allowed.
  • Initial stroke severity \>/= NIHSS 3.
  • Clinical diagnosis of PD.
  • Anti-parkinsonian medical treatment (dopaminergic or other).

You may not qualify if:

  • Informed consent not provided
  • Other neurological or psychiatric disease which is expected to influence the patient's ability to participate in the trial according to the investigator
  • Not able to participate according to investigator
  • Patients with massive anosognosia for executive dysfunction or patients with no subjective feeling of executive dysfunction (Patient sustains total denial of executive symptoms over time)
  • Patients with severe aphasia, in which it is unclear whether the patient's performance on a neuropsychological test-battery is due to aphasia and not executive dysfunction.
  • Diagnosis of PD Dementia according to the MDS PD Dementia criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Bispebjerg Hospital

Copenhagen, Denmark

RECRUITING

Rigshospitalet

Copenhagen, Denmark

RECRUITING

MeSH Terms

Conditions

Parkinson DiseaseStrokeHeart ArrestCognitive Dysfunction

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesCerebrovascular DisordersVascular DiseasesCardiovascular DiseasesHeart DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Hanne Christensen, Professor

    Bispebjerg Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hanne Christensen, Professor

CONTACT

Katrine Sværke, M.Sc. Psych.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Because of the nature of the intervention, masking participants and investigators is not possible. Outcome assessors will be masked to the group allocation of participants.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two parallel groups will be included in this study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 3, 2020

First Posted

January 14, 2020

Study Start

June 1, 2020

Primary Completion

December 31, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

February 20, 2025

Record last verified: 2025-02

Locations